Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.08Cr 1Cr 92.43L 1.75Cr 118.28Cr 1.79Cr 12Cr 4.67Cr 58Cr 4.64Cr 4.54Cr 200.93Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.25Cr 2.08Cr 1.92Cr 3.64Cr 246.03Cr 3.72Cr 25Cr 9.72Cr 120.4Cr 9.65Cr 9.44Cr 417.94Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 month-25.00%
3 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 15/06/2020
Director/Board Member - 15/11/2019
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-40.00% 74.12L
-1.26%-0.62%+19.70%-0.70% 19TCr
-2.86%+3.16%-21.28%+25.30% 15TCr
-1.76%-1.52%-4.94%-18.15% 14TCr
-1.08%+4.06%-56.24%-14.30% 6.66TCr
-1.24%+1.79%+22.58%+3.74% 5.39TCr
+0.16%-2.15%-27.83%-31.18% 4.36TCr
-1.58%-3.24%+6.66%+10.32% 3.65TCr
-1.81%-2.64%+5.85%+39.36% 3.61TCr
-6.33%+2.36%-19.78%-4.62% 2.97TCr
Average -1.13%+1.09%-2.53%-3.02% 7.38TCr
Weighted average by Cap. -0.44%+1.62%-5.33%+0.93%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.77L 7.94Cr 12L 80.76L 31.38L 3.89Cr 31.15L 30.47L 13Cr 16.09L 14.12L 13.03L 12.04L 22.83L 15Cr 23.28L 1.57Cr 60.88L 7.54Cr 60.44L 59.12L 26Cr
Net income -11.6L -10.17L -9L -9L -16.45L -11Cr -16.78L -1.13Cr -43.87L -5.43Cr -43.55L -42.6L -19Cr -3L -3L -2L -2L -4L -2.78Cr -4L -28.21L -10.96L -1.36Cr -10.88L -10.65L -4.71Cr
Net Debt 1.31Cr 1.15Cr 1.06Cr 97.78L 1.85Cr 125.13Cr 1.89Cr 13Cr 4.94Cr 61Cr 4.91Cr 4.8Cr 212.56Cr 1.33Cr 1.17Cr 1.08Cr 99.83L 1.89Cr 127.75Cr 1.93Cr 13Cr 5.05Cr 63Cr 5.01Cr 4.9Cr 217.02Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
08/26/08 $0.000300 0.00% 45,23,182
07/26/07 $0.000300 +20.00% 1,02,53,333
06/26/06 $0.000250 -16.67% 41,87,384
02/26/02 $0.000300 0.00% 25,40,317
01/26/01 $0.000300 0.00% 1,98,76,498
  1. Stock Market
  2. Stocks
  3. BIEL Stock